Cleared Traditional

K163272 - AXIOS Stent and Electrocautery Enhanced Delivery System (FDA 510(k) Clearance)

Feb 2017
Decision
89d
Days
Class 2
Risk

K163272 is an FDA 510(k) clearance for the AXIOS Stent and Electrocautery Enhanced Delivery System. This device is classified as a Pancreatic Stent, Covered, Metallic, Removable (Class II - Special Controls, product code PCU).

Submitted by Boston Scientific Corporation (Marlboro, US). The FDA issued a Cleared decision on February 18, 2017, 89 days after receiving the submission on November 21, 2016.

This device falls under the Gastroenterology & Urology FDA review panel. Regulated under 21 CFR 876.5015. To Facilitate Transmural Endoscopic Drainage Of Pancreatic Pseudocysts.

Submission Details

510(k) Number K163272 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 21, 2016
Decision Date February 18, 2017
Days to Decision 89 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF

Device Classification

Product Code PCU — Pancreatic Stent, Covered, Metallic, Removable
Device Class Class II - Special Controls
CFR Regulation 21 CFR 876.5015
Definition To Facilitate Transmural Endoscopic Drainage Of Pancreatic Pseudocysts